BeFutur (Suisse) S.A.

The company's mission is to enhance human life through a customized care treatment approach, using advances in cells and tissues engineering. By abiding to its mission, BeFutur Biotechnologies is making a difference in the lives of millions of customers across the globe.

Starting with a dream and a handful of people, this small biotech start-up was created in Switzerland, in 1998, with a very specialized R&D team. The essence behind the foundation of this company was research centered on the autologous human cells using a serum free medium to treat incurable diseases. Hence, intense clinical trials were performed in order to propose new treatments in cardiology, burning care, aesthetic medicine, hepatology, ophthalmology, orthopaedic surgery, dermatology. This focus on treatment and prevention of medical diseases resulted in the development of:

Cells and tissues engineering for aesthetic surgery, cardiology and orthopaedic surgery. Cellular implants for regeneration of diseased tissues.

BeFutur research team is headed by a strong team of scientists, researchers and medical doctors, and works closely with renowned medical institutions. The company with offices and facilities in Switzerland, France and Canada is fully operational and the R&D team, together with its board of scientific and business directors, are guiding the company to new heights of unequalled research and expanded medical frontiers.

Today, BeFutur is continuing its mission of extending human life and is bound to provide an unwavering commitment to the values of excellence, reliability, growth, innovation and fairness to humanity.